BOSTON (AP) _ Vertex Pharmaceuticals Inc. (VRTX) on Tuesday reported third-quarter profit of $851.9 million.

On a per-share basis, the Boston-based company said it had net income of $3.28. Earnings, adjusted for one-time gains and costs, came to $3.56 per share.

The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $3.12 per share.

The drugmaker posted revenue of $1.98 billion in the period, also surpassing Street forecasts. Eight analysts surveyed by Zacks expected $1.85 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News